Our bold ambition is to stop, reverse, and cure CVRM diseases by maximizing our medicines, delivering innovative solutions, and advancing our pipeline.

The impacts of CVRM diseases on people, society and our planet are immense and growing, yet they remain underdiagnosed, undertreated and their interconnections under-recognized. These conditions affect hundreds of millions of people around the world; we estimate that one in three people with a CVRM disease are living with two or more of these chronic diseases.

Our ambition is to enhance care to improve outcomes for the millions of people who are living with the complexities of CVRM diseases, to intervene early to protect vital organs, slow or stop disease progression, and one day even cure these often debilitating, progressive and life-threatening conditions.

Through understanding the interconnections of these conditions, we’re able to extend the use of our existing medicines and build one of the world’s broadest, deepest and strongest CVRM pipelines. 9 By 2032, we aim to be leading the world in CVRM therapies, helping to change the course and reach of medical practice.

Read more

We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. Our portfolio of inhaled and biologic medicines, and our pipeline for the future, seek to address the challenges and vast unmet medical needs patients face today.

With five decades of experience, we are an established leader in respiratory care and a disruptor in immunology. We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. Our portfolio of inhaled and biologic medicines, and our pipeline for the future, seek to address the challenges and vast unmet medical needs patients face today. By following the science, we are focused on sustainably addressing tough and complex unsolved problems. Our approach involves targeting the underlying biology, developing effective new drug modalities and combinations and applying a precision medicine approach from the start of discovering medicines, all while driving earlier detection, diagnosis and intervention.

Read more

We have a bold ambition to provide cures for cancer in every form. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save the lives of people around the world.

Our Oncology strategy is built with one goal in mind – to push the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer. Our broad pipeline of next-generation medicines, together with our focus on excellence in execution, are aimed at expanding treatment options and improving outcomes for patients with solid tumours and haematological cancers. 

Read more

Our ambition is to develop and deliver transformative vaccines and antibodies, providing long-lasting immunity for millions of people, where the burden of disease is greatest. 

We are committed to developing and delivering transformative vaccines and antibodies, providing long lasting immunity for millions of people, where the burden of disease is greatest. During the COVID-19 pandemic, we played an important role as part of a truly global effort to respond to a new and unprecedented challenge.1 We will continue to advance science in vaccines and immune therapies and work with partners to drive improvements in public health and ensure our science reaches millions more people.

Read More

We’re interested in cutting-edge technologies to enhance the quality, effectiveness, and productivity of our research and translational capabilities, including: 

• Target validation tools and technologies
• Novel HTS/lead generation approaches
• Novel chemical libraries with evidence of biological relevance
• Predictive safety and predictive efficacy platforms
• Drug delivery platforms and medical device technologies
• Novel delivery, manufacturing and analytical processes
• New systems for drug targeting
• Stem cell biology
• Novel technologies for antibodies and vaccines
• Application of artificial intelligence and machine learning to drug discovery and development
• Point-of-care testing
• Monitoring devices
• CRISPR

The work we do is guided by people living with rare and devastating diseases. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives.

Read more